Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SILO
#3953
Silo Pharma, Inc. Common Stock
0.3
7
+5.71%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
+5.71%
Mudança mensal
-2.63%
Mudança em 6 meses
-42.19%
Mudança anual
-72.59%
Fechamento anterior
0.3
5
Open
0.3
7
Bid
Ask
Low
0.3
7
High
0.3
7
Volume
3
Mercados
Ações
Cuidados de saúde
SILO
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
4.48 M
4.48 M
4.48 M
9.4 M
13.32 M
—
Valuation ratios
Enterprise value
72.01 K
85.37 K
2.11 M
1.59 M
5.27 M
9.06 M
Price to earnings ratio
-0.92
-0.75
-1.03
-0.62
-0.75
-3.14
Price to sales ratio
47.15
45.43
58.19
35.9
46.16
185.68
Price to cash flow ratio
-0.9
-0.85
-0.94
-0.5
-0.69
-2.99
Price to book ratio
0.14
0.65
0.19
0.12
0.18
1.14
Enterprise value to EBITDA ratio
—
-0.02
—
-0.31
-1
—
Profitability ratios
Return on assets %
-0.11
-0.23
-0.17
-0.18
-0.17
-0.76
Return on equity %
-0.14
-0.34
-0.26
-0.24
-0.22
-1.07
Return on invested capital %
-1 065.21
-1 935.59
-1 182.24
-1 388.27
-1 430.41
-5 936.51
Gross margin %
91.91
91.9
91.9
91.91
-14.77
260.94
Operating margin %
-5 603.63
-10.06 K
-6 069.68
-6 926.77
-6 388.16
-29.44 K
EBITDA margin %
-5 586.48
-10.04 K
-6 052.53
-6 913.05
-6 371.86
-29.38 K
Net margin %
-5 152.92
-9 600.69
-5 721.94
-6 681.24
-6 160.54
-28.16 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
7.91
4.29
4.73
6.07
8.7
23.8
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.31
-0.25
-0.37
-0.2
-0.1
-0.92
EBIT per share
-0.23
-0.49
-0.24
-0.2
-0.12
-1.06
EBITDA per share
-0.23
-0.49
-0.24
-0.2
-0.12
-1.06
Total debt per share
—
—
—
—
—
—
Cash per share
1.86
1.92
1.22
1
0.63
4.76
Net current asset value per share
1.92
1.93
1.25
1.01
0.66
4.86
Tangible book value per share
1.52
1.3
0.84
0.75
0.51
3.4
Working capital per share
1.68
1.48
0.99
0.85
0.58
3.9
Book value per share
1.58
1.37
0.89
0.78
0.54
3.58
Notícias
Ações da Silo Pharma disparam com programa de recompra de US$ 1 milhão
Silo Pharma stock surges on $1M share buyback program
Silo Pharma autoriza programa de recompra de ações de US$ 1 milhão
Silo Pharma authorizes $1 million stock buyback program
Japão concede patente para tratamento de TEPT da Silo Pharma
Japan grants patent for Silo Pharma’s PTSD treatment
Silo Pharma assina carta de intenções com Allucent para ensaios clínicos do spray nasal SPC-15
Silo Pharma signs LOI with Allucent for SPC-15 nasal spray clinical trials
CEO da Silo Pharma, Weisblum, compra US$ 735 em ações da empresa
Silo Pharma CEO Weisblum buys $735 in company stock
Silo Pharma selects Allucent to support PTSD treatment IND submission
Silo Pharma selects Alphaledger T12 fund for blockchain asset investments